Cargando…

Association of APOE-Independent Alzheimer Disease Polygenic Risk Score With Brain Amyloid Deposition in Asymptomatic Older Adults

BACKGROUND AND OBJECTIVES: Brain amyloid deposition, a major risk factor for Alzheimer disease (AD), is currently estimated by measuring CSF or plasma amyloid peptide levels or by PET imaging. Assessing genetic risks relating to amyloid deposition before any accumulation has occurred would allow for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xicota, Laura, Gyorgy, Beata, Grenier-Boley, Benjamin, Lecoeur, Alexandre, Fontaine, Gaëlle, Danjou, Fabrice, Gonzalez, Jorge Samper, Colliot, Olivier, Amouyel, Philippe, Martin, Garance, Levy, Marcel, Villain, Nicolas, Habert, Marie-Odile, Dubois, Bruno, Lambert, Jean-Charles, Potier, Marie-Claude
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421597/ https://www.ncbi.nlm.nih.gov/pubmed/35606148 http://dx.doi.org/10.1212/WNL.0000000000200544

Ejemplares similares

Multi-omics signature of brain amyloid deposition in asymptomatic individuals at-risk for Alzheimer's disease: The INSIGHT-preAD study
por: Xicota, Laura, et al.
Publicado: (2019)

Awareness of cognitive decline trajectories in asymptomatic individuals at risk for AD
por: Cacciamani, Federica, et al.
Publicado: (2020)

The meta-memory ratio: a new cohort-independent way to measure cognitive awareness in asymptomatic individuals at risk for Alzheimer’s disease
por: Gagliardi, Geoffroy, et al.
Publicado: (2020)

An Automated Pipeline for the Analysis of PET Data on the Cortical Surface
por: Marcoux, Arnaud, et al.
Publicado: (2018)

Modifications of the endosomal compartment in fibroblasts from sporadic Alzheimer’s disease patients are associated with cognitive impairment
por: Xicota, Laura, et al.
Publicado: (2023)

Theta Band-Power Shapes Amyloid-Driven Longitudinal EEG Changes in Elderly Subjective Memory Complainers At-Risk for Alzheimer’s Disease
por: Spinelli, Giuseppe, et al.
Publicado: (2022)

miRNA-dependent target regulation: functional characterization of single-nucleotide polymorphisms identified in genome-wide association studies of Alzheimer’s disease
por: Delay, Charlotte, et al.
Publicado: (2016)

Impact of APOE gene polymorphisms on the lipid profile in an Algerian population
por: Boulenouar, Houssam, et al.
Publicado: (2013)

Age-dependent effect of APOE and polygenic component on Alzheimer's disease
por: Bellou, Eftychia, et al.
Publicado: (2020)

MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints
por: Vergallo, Andrea, et al.
Publicado: (2021)

Partial Volume Correction Increases the Sensitivity of 18F-Florbetapir-Positron Emission Tomography for the Detection of Early Stage Amyloidosis
por: Teipel, Stefan J., et al.
Publicado: (2021)

Polygenic Risk Score Analysis of Alzheimer’s Disease in Cases without APOE4 or APOE2 Alleles
por: Escott-Price, V., et al.
Publicado: (2018)

No association of cortical amyloid load and EEG connectivity in older people with subjective memory complaints
por: Teipel, Stefan, et al.
Publicado: (2017)

Association of the Polygenic Risk Score With the Probability of Prodromal Parkinson’s Disease in Older Adults
por: Maraki, Maria I., et al.
Publicado: (2021)

Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study
por: Baldacci, Filippo, et al.
Publicado: (2020)

Risk of dementia in APOE ε4 carriers is mitigated by a polygenic risk score
por: Ebenau, Jarith L., et al.
Publicado: (2021)

Ultrastructural and dynamic studies of the endosomal compartment in Down syndrome
por: Botté, Alexandra, et al.
Publicado: (2020)

Polygenic risk scores for Alzheimer's disease are related to dementia risk in APOE ɛ4 negatives
por: Najar, Jenna, et al.
Publicado: (2021)

Polygenic score modifies risk for Alzheimer's disease in APOE ε4 homozygotes at phenotypic extremes
por: Huq, Aamira J., et al.
Publicado: (2021)

Impaired memory-guided attention in asymptomatic APOE4 carriers
por: Zimmermann, Jacqueline, et al.
Publicado: (2019)

Associations of the APOE ε2 and ε4 alleles and polygenic profiles comprising APOE-TOMM40-APOC1 variants with Alzheimer’s disease biomarkers
por: Kulminski, Alexander M., et al.
Publicado: (2022)

A comprehensive analysis of methods for assessing polygenic burden on Alzheimer’s disease pathology and risk beyond APOE
por: Altmann, Andre, et al.
Publicado: (2019)

Lipid Dys-Homeostasis Contributes to APOE4-Associated AD Pathology
por: Lazar, Adina-Nicoleta, et al.
Publicado: (2022)

Considering the APOE locus in Alzheimer’s disease polygenic scores in the Health and Retirement Study: a longitudinal panel study
por: Ware, Erin B., et al.
Publicado: (2020)

Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment
por: Pyun, Jung-Min, et al.
Publicado: (2021)

Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older population
por: Riaz, Moeen, et al.
Publicado: (2021)

Frontal presentation of Alzheimer's disease: a series of patients with biological evidence by CSF biomarkers
por: de Souza, Leonardo Cruz, et al.
Publicado: (2013)

Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping
por: Belloy, Michael E., et al.
Publicado: (2022)

Integrated analysis of direct and proxy genome wide association studies highlights polygenicity of Alzheimer’s disease outside of the APOE region
por: de la Fuente, Javier, et al.
Publicado: (2022)

Optimalization of preparation of apo-cytochrome b(5) utilizing apo-myoglobin
por: Mrázová, Barbora, et al.
Publicado: (2008)

Step by step: towards a better understanding of the genetic architecture of Alzheimer’s disease
por: Lambert, Jean-Charles, et al.
Publicado: (2023)

Polygenic resilience scores capture protective genetic effects for Alzheimer’s disease
por: Hou, Jiahui, et al.
Publicado: (2022)

Apolipoprotein E moderates the association between Non-APOE Polygenic Risk Score for Alzheimer’s Disease and Aging on Preclinical Cognitive Function
por: Xu, Yuexuan, et al.
Publicado: (2023)

APOE ɛ4, but not polygenic Alzheimer’s disease risk, is related to longitudinal decrease in hippocampal brain activity in non-demented individuals
por: Håglin, Sofia, et al.
Publicado: (2023)

Clinica: An Open-Source Software Platform for Reproducible Clinical Neuroscience Studies
por: Routier, Alexandre, et al.
Publicado: (2021)

A polygenic risk score for Alzheimer’s disease constructed using APOE-region variants has stronger association than APOE alleles with mild cognitive impairment in Hispanic/Latino adults in the U.S.
por: Sofer, Tamar, et al.
Publicado: (2023)

Multiomics integrative analysis identifies APOE allele-specific blood biomarkers associated to Alzheimer’s disease etiopathogenesis
por: Madrid, Laura, et al.
Publicado: (2021)

A Polygenic Approach to the Study  of Polygenic Diseases
por: Lvovs, D., et al.
Publicado: (2012)

Influence of polygenic risk scores for schizophrenia and resilience on the cognition of individuals at-risk for psychosis
por: He, Qin, et al.
Publicado: (2021)

Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer’s disease polygenic risk score
por: Tomassen, Jori, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_on35rg4qd0c7pi4t9kk4kism0v